Benzodiazepine-Based Drug Discovery (Paperback)

Benzodiazepine-Based Drug Discovery covers benzodiazepines and benzothiazepines, which constitute two pivotal classes of heterocyclic compounds widely used as core structures of medicinal drugs for the treatment of depression, epilepsy, seizures and muscle spasms. 1,4-Benzodiazepine, 1,5-benzodiazepine, and 1,5-benzothiazepine are the most studied groups of benzodiazepines and benzothiazepines because of their outstanding potential biological activities. This book offers a broad range of recent developments and detailed coverage of the synthesis and biological activities of the drugs based on benzodiazepine and benzothiazepine matrixes, and is an ideal reference guide to researchers working in organic and medicinal chemistry. The importance of these privileged pharmacophores is not limited to the treatment of psychotic disorders because minor changes in the structures can generate various biological activities. They represent a wide range of therapeutic functions such as anticonvulsant, antianxiety, anti-depressant, antiviral, anti-HIV, anti-inflammatory, anticoagulant, anti-obesity, endothelin antagonist, cholecystokinin antagonist, and vasopressin receptor antagonist activities.

General

Imprint:	Elsevier Science Publishing Co Inc
Country of origin:	United States
Series:	Heterocyclic Drug Discovery
Release date:	August 2022
First published:	2022
Authors:	Farzad Zamani • Esmail Doustkhah
Dimensions:	229 x 152mm (L x W)
Format:	Paperback
Pages:	338
ISBN-13:	978-0-12-824516-3
Categories:	Books > Science & Mathematics > Chemistry > Organic chemistry > General Promotions
LSN:	0-12-824516-6
Barcode:	9780128245163

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!